A new study from Northwestern University has found that two widely prescribed type 2 diabetes medications—sulfonylureas and ...

Dr. Akshay Jain MD, FRCPC, FACE, CCD, ECNU, DABIM, DABOM, Clinical and Research Endocrinologist, talks about novel ...

Research shows that a common type of diabetes medication could help cancer patients make a better long-term recovery. Many cancer patients go on to develop heart failure -- because of the cancer ...

Many cancer patients go on to develop heart failure - because of the cancer itself and also due to chemotherapy. But a new ...

Indian drug companies are set to revolutionize diabetes treatment with affordable generic versions of Empagliflozin, ...

A widely used diabetes medication, SGLT2 inhibitors, has shown a surprising benefit for cancer patients—protecting their ...

SGLT2 inhibitors, a diabetes medication, may protect the heart and reduce hospitalizations for cancer patients, particularly ...

A common type of diabetes medication could help cancer patients make a better long-term recovery, according to new research from the University of East Anglia.

Whether you have type 2 diabetes, obesity or just a few extra pounds that you’d like some help shedding, chances are you’re ...

The FDA says state-licensed compounding pharmacies must immediately stop making compound versions of GLP-1 drugs. Larger, national licensed facilities making compound versions of Zepbound have until ...